Bed rest

Inovia Vein Calls for Increased Awareness Around Deep Vein Thrombosis Risks During DVT Awareness Month

Retrieved on: 
Tuesday, March 5, 2024
Health, Consumer, Women, Surgery, Seniors, Other Health, Men, Pulmonary embolism, Pacific Northwest, Education, Tenderness, Obesity, Pain, Deep vein thrombosis, Swelling, Leg, DVT, Pregnancy, Vein, Risk, Patient, Bed rest, Trauma, Cancer, Birth control

With March being nationally recognized as Deep Vein Thrombosis (DVT) Awareness Month , Inovia Vein , a leading provider of world-class vein health services, is calling for enhanced education and awareness about this potentially life-threatening condition.

Key Points: 
  • With March being nationally recognized as Deep Vein Thrombosis (DVT) Awareness Month , Inovia Vein , a leading provider of world-class vein health services, is calling for enhanced education and awareness about this potentially life-threatening condition.
  • Inovia Vein’s vein health experts are stepping up to spread the word about the condition.
  • “That said, at Inovia Vein, we believe every month should be ‘DVT Awareness Month,’ and we are dedicated to educating the communities we serve and beyond about prevention and education.
  • Inovia Vein, the leading provider of vein health services, is dedicated to offering comprehensive and compassionate care to patients with venous disorders.

Former Mrs. USA to Open Lila Maternity Retail Store in Nashville, Featuring Stylishly Reimagined Labor Gowns for Pre- and Postpartum Women

Retrieved on: 
Friday, February 9, 2024
Woman, Collection, Social media, News, Twin, Human, Bed rest, Learning

NASHVILLE, Tenn., Feb. 9, 2024 /PRNewswire-PRWeb/ -- Lila Maternity, designers of modern and comfortable maternity gowns, announces it has officially moved into the future home of its first retail shop at 300 Indian Lakes Blvd. in Hendersonville. Founded by a military vet and former Mrs. USA, Lila Maternity is best known for its stylish and reimagined labor gowns for pre- and postpartum women, which have become a social media phenomenon. A weekend-long celebration is planned for March 15 through 17.

Key Points: 
  • Founded by a military vet and former Mrs. USA, Lila Maternity is best known for its stylish and reimagined labor gowns for pre- and postpartum women, which have become a social media phenomenon.
  • "We envision the Lila Maternity store becoming a go-to for everything pre- and postpartum moms and their babies need in our community," said Founder Caitlyn Schollmeier.
  • "We envision the Lila Maternity store becoming a go-to for everything pre- and postpartum moms and their babies need in our community.
  • Lila Maternity will mark the second maternity store to serve the local community and will be open to the public seven days a week with no appointment required.

Children's Miracle Network Hospitals® Announces 11 New National Champions Advocating for Pediatric Healthcare

Retrieved on: 
Tuesday, January 2, 2024
Long, PVL, Walking, Nyla, Children's Specialized Hospital, Family, Hospital, Children's Hospital, Occupational therapy, Arrhythmia, Research, State, PTLS, Hope, Bed rest, NICU, Health, Organic, Eye, Infant, Nationwide Children's Hospital, Cancer, Cerebral palsy, Syndrome, Love, Fertilisation, Doctor of Philosophy, Long QT syndrome, Genetic testing, Children's Miracle Network Hospitals, Safety, Prediabetes, DSM-IV codes, National championship, Life, Health insurance

SALT LAKE CITY, Jan. 2, 2024 /PRNewswire-PRWeb/ -- Children's Miracle Network Hospitals proudly introduces its newest cohort of National Champions, a group of extraordinary ambassadors dedicated to raising awareness about the critical need for charitable donations to support pediatric healthcare. These inspirational children and their families hail from diverse backgrounds and represent various member hospitals across the U.S. Each Champion's unique journey exemplifies the profound impact of donations on their lives, underscoring the urgent need to support Children's Miracle Network Hospitals.

Key Points: 
  • Adeline - Duke Children's Hospital (Age: 8)
    "The stories of our National Champions emphasize the transformative impact of charitable donations on pediatric healthcare," said Aimee Daily, Ph.D., President & CEO, Children's Miracle Network Hospitals.
  • Children's Miracle Network Hospitals, the largest fundraising network for children's hospitals in the U.S. and Canada, partners with leading pediatric healthcare providers to give kids a world of possibilities.
  • "The stories of our National Champions emphasize the transformative impact of charitable donations on pediatric healthcare," said Aimee Daily, Ph.D., President & CEO, Children's Miracle Network Hospitals.
  • National Champions are a group of ambassadors for Children's Miracle Network Hospitals located throughout the U.S. As National Champions, they're key to informing the public that children's hospitals are charities in need of donations.

BioAge Labs Announces Plans for Phase 2 Trial of First-in-Class Apelin Receptor Agonist BGE-105/Azelaprag Co-Administered With Tirzepatide for Treatment of Obesity, in Collaboration With Lilly’s Chorus Organization

Retrieved on: 
Thursday, October 26, 2023
Health, Fitness & Nutrition, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Science, Lilly, Eli Lilly and Company, Ageing, Concept, Biomarker, Therapy, Heart, Obesity, Weight loss, Apelin, Doctor of Philosophy, Agonal respiration, Maintenance, Exercise, Metabolism, Drug development, Incretin, Muscle atrophy, Biology, Amgen, Bed rest, Chemistry, Central nervous system, Pharmaceutical industry, Dietary supplement, Chorus

As part of the collaboration, Lilly will also provide BioAge with tirzepatide.

Key Points: 
  • As part of the collaboration, Lilly will also provide BioAge with tirzepatide.
  • “We are thrilled to work directly with the clinical development experts at Chorus and benefit from Lilly’s expertise in obesity drug development,” said Kristen Fortney, PhD, CEO and co-founder of BioAge.
  • “Our Phase 2 trial is designed to assess whether azelaprag can substantially increase the weight loss achieved with drugs of the incretin class.
  • Apelin signaling has demonstrated multiple benefits in energy metabolism in mouse models, including increased insulin sensitivity and reduction in fat mass.

CurvaFix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly

Retrieved on: 
Thursday, October 5, 2023
Other Health, Research, Consumer, Medical Devices, Hospitals, Science, Surgery, Biotechnology, Seniors, FDA, Other Science, Health, BMI, FFP, Pain, Multimedia, Physician, ACEP, Foster, American College, Visual analogue scale, Pelvis, Weight-bearing, Mortality, Emergency, University, Patient, Bed rest, CT, Trauma, Emergency medicine, Medicine, Surgeon, Fellow of the American College of Emergency Physicians, VAS, Dentistry, Osteoporosis

CurvaFix, Inc ., a developer of medical devices to repair fractures in curved bones, announced today it will showcase the CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) at the American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, October 9-11, 2023, in booth #1935.

Key Points: 
  • CurvaFix, Inc ., a developer of medical devices to repair fractures in curved bones, announced today it will showcase the CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) at the American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, October 9-11, 2023, in booth #1935.
  • View the full release here: https://www.businesswire.com/news/home/20231005741542/en/
    The CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) will be showcased at the American College of Emergency Physicians (ACEP) Scientific Assembly, Oct. 9-11 in booth #1935.
  • As such, we are pleased to make our debut at the ACEP Scientific Assembly, the world’s largest emergency medicine educational conference,” said Mark Foster , chief executive officer at CurvaFix.
  • “Emergency Medicine physicians are often the first point of care for patients who sustain geriatric pelvic fractures or fragility fractures of the pelvis.

Exercising during a hospital stay linked with faster recovery – new research

Retrieved on: 
Monday, August 7, 2023
Exercise, Medicine, Hospice and palliative medicine, Disability, Incontinence, Constipation, Research, Facial muscles, Falls, Movement, Intensive care medicine, Walking, System, Patient, Risk, Bed rest, Deep vein thrombosis, Weakness, Boredom, Ageing, Caregiver, Death, Rest, Mental health, Respiratory failure, Hospital, Nursing, Residential care, Dietary supplement

Our latest study shows that physical activity may help to counteract the effects of bed rest.

Key Points: 
  • Our latest study shows that physical activity may help to counteract the effects of bed rest.
  • We found that even just 25 minutes a day of walking while in hospital can significantly speed up recovery for older adults – and it may also prevent new hospital stays in the future.
  • This suggests physical activity may protect against the harmful effect of too much bed rest during hospital stays.
  • Other studies have also shown the benefits of physical activity during a hospital stay.

The importance of movement

    • This leads to deconditioning, loss of strength, and ultimately a reduced ability to do daily tasks independently.
    • Prolonged bed rest also decreases blood flow and lung capacity and increases the risk of deep vein thrombosis.
    • And the benefits of movement aren’t only physical.
    • There’s no “one size fits all” solution, but every movement counts.

Opioids don't relieve acute low back or neck pain – and can result in worse pain, new study finds

Retrieved on: 
Wednesday, June 28, 2023
People, Neck pain, Education, Naloxone, Low back pain, Oxycodone, Quality of life, Constipation, Immunity, GP, Research, Thought, Pain, Death, Back pain, Dizziness, Patient, Poisoning, Risk, Time, Bed rest, Nausea, Ibuprofen, Lancet, Complex, Birth control, Poultry farming, Cereal, Dietary supplement, Nursing

But our new study, published today in the Lancet medical journal, found opioids do not relieve “acute” low back or neck pain (lasting up to 12 weeks) and can result in worse pain.

Key Points: 
  • But our new study, published today in the Lancet medical journal, found opioids do not relieve “acute” low back or neck pain (lasting up to 12 weeks) and can result in worse pain.
  • Our findings show opioids should not be recommended for acute low back pain or neck pain.
  • A change in prescribing for low back pain and neck pain is urgently needed in Australia and globally to reduce opioid-related harms.

Comparing opioids to a placebo

    • Oxycodone is an opioid pain medicine which can be given orally.
    • Naloxone, an opioid-reversal drug, reduces the severity of constipation while not disrupting the pain relieving effects of oxycodone.
    • Participants took the opioid or placebo for a maximum of six weeks.

What did we find?

    • Nor were there benefits to other outcomes such as physical function, quality of life, recovery time or work absenteeism.
    • More people in the group treated with opioids experienced nausea, constipation and dizziness than in the placebo group.
    • More people in the opioid group reported pain at one year: 66 people compared to 50 in the placebo group.

What will this mean for opioid prescribing?

    • For acute low back pain, guidelines recommend patient education and advice, and if required, anti-inflammatory pain medicines such as ibuprofen.
    • Instead of advising opioid use for these conditions in selected circumstances, opioids should be discouraged without qualification.

Change is possible


    Complex problems such as opioid use need smart solutions, and another study we recently conducted provides convincing data opioid prescribing can be successfully reduced. The study involved four hospital emergency departments, 269 clinicians and 4,625 patients with low back pain. The intervention comprised of:
    • Key to this successful approach is that we worked with clinicians to develop suitable pain-management treatments without opioids that were feasible in their setting.
    • Read more:
      Why does my back get so sore when I'm sick?
    • Our research provides compelling evidence opioids have a limited role in the management of acute low back and neck pain.
    • The challenge is getting this new information to clinicians and the general public, and to implement this evidence into practice.

Should I get the flu vaccine? South African experts say yes - here's why

Retrieved on: 
Saturday, June 10, 2023
People, Infection, Heart, Myalgia, Pregnancy, Diabetes, HIV, Vaccination, Fever, Immunity, National Institute, Research, Cough, National Centre for Disease Control, Death, Patient, Risk, Bed rest, Genetically modified bacteria, World, WHO, Headache, Pneumonia, World Health Organization, Vaccine

Influenza (flu) is an acute respiratory illness caused by an infection of the respiratory tract with the influenza virus.

Key Points: 
  • Influenza (flu) is an acute respiratory illness caused by an infection of the respiratory tract with the influenza virus.
  • For most people, recovering from flu involves a few days of mild symptoms which resolve with symptomatic treatment.
  • The main reason to get the flu vaccine is to lower your risk of being sick with flu.
  • But certain groups of people are at risk of having severe flu illness or having flu complications or death.

CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans.

Retrieved on: 
Monday, December 26, 2022
Maker, Organization, Degenerative disease, Nutrition, CJ CheilJedang, Diabetes, Patient, Organic acid, Food, Mayo Clinic, Drug discovery, Obesity, Partnership, Entertainment, Growth, CJ, Marketing, Division, Trifecta Entertainment & Media, Malnutrition, Muscle atrophy, Muscle, Bed rest, Multimedia, CJ Group, Ageing, Metabolism, Skeleton, Doctor of Philosophy, Investment, Arthritis, Cancer, Research, MN, Foodservice, Sarcopenia, Pharmaceutical industry, Dietary supplement, Fine chemical, Endocrinology

The technical and commercial collaboration will result in the global launch of several nutraceutical and dietary supplement products that have the ability to inhibit muscle atrophy while improving strength and endurance.

Key Points: 
  • The technical and commercial collaboration will result in the global launch of several nutraceutical and dietary supplement products that have the ability to inhibit muscle atrophy while improving strength and endurance.
  • It particularly affects older people with arthritis, on bed rest due to body injuries such as accidental falls and malnutrition through illnesses such as cancer.
  • Optimal muscle health is also important in sports performance and lack of physical exercise where nutritional supplementation can be beneficial.
  • These small molecules are intended to create new food products for muscle health, while others are being developed as pharmaceuticals for obesity and type 2 diabetes.

BioAge Hosting Webcast to Discuss Newly Announced Phase 1b Data Demonstrating BGE-105 Significantly Improves Muscle Atrophy in Older Volunteers on Bed Rest and Detail Phase 2 Plans

Retrieved on: 
Wednesday, December 14, 2022
Biotechnology, Pharmaceutical, Health, Clinical Trials, Ageing, Therapy, Muscle atrophy, Duke University, UC, Human nutrition, APJ, Lung, MD, Conditional sentence, United States Senate Select Committee on Nutrition and Human Needs, Diaphragm, Doctor of Philosophy, Q&A, ICU, Toronto, Biomarker, Patient, Prevalence, Body composition, Ventilation, Degenerative disease, Research, Muscle, Atrophy, NLRP3, Kaiser Permanente, FRCPC, University Health Network, Kinemation, Khosla Ventures, University, KOL, Interest, Geriatrics, Mortality, Sarcopenia, University of California, Berkeley, Myopathy, Bed rest, Medicare, Tracheotomy, Risk, Pharmaceutical industry, Medical imaging, Dietary supplement, Medicine

William Evans, PhD is Adjunct Professor of Human Nutrition at UC Berkeley and Medicine (Geriatrics) at Duke University.

Key Points: 
  • William Evans, PhD is Adjunct Professor of Human Nutrition at UC Berkeley and Medicine (Geriatrics) at Duke University.
  • Previously, he was President of the Muscle and Health Division at KineMed and VP and Head of GlaxoSmithKlines Muscle Metabolism Discovery Performance Unit.
  • Phase 1b trial data released to date demonstrate that in healthy volunteers 65 and older on 10-day strict bed rest, BGE-105 prevented muscle atrophy as reflected by improvements in multiple parameters, including the dimensions of leg muscles, muscle quality, and muscle protein synthesis.
  • BioAge has multiple programs targeting muscle, immune, and brain aging, including the clinical-stage apelin receptor agonist BGE-105 and a differentiated CNS-penetrant NLRP3 inhibitor.